Siemens Healthineers (OTCMKTS:SMMNY) Posts Earnings Results, Beats Expectations By $0.11 EPS

Siemens Healthineers (OTCMKTS:SMMNY) announced its quarterly earnings results on Friday. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.11, Zacks reports.

Siemens Healthineers Stock Down 0.6%

SMMNY stock traded down $0.13 during trading on Friday, reaching $21.38. The stock had a trading volume of 125,212 shares, compared to its average volume of 159,718. The stock’s 50 day moving average is $19.94 and its two-hundred day moving average is $21.82. Siemens Healthineers has a 52 week low of $19.20 and a 52 week high of $28.92.

Analyst Ratings Changes

Separately, Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.